Table 1.
Overview of Microbiological Investigations Performed on Samples and Diagnostic Criteria
| Specimen | Infectious agent | Assay | Diagnostic criteria |
| BAL fluid | Aerobic bacteria | Culture | ≥104 cfu/mL (cut-off value) |
| Viruses | Culture | Growth | |
| Respiratory virusesa | Multiplex PCR | Positive | |
| Atypicalb | Multiplex PCR | Positive | |
| NPA | Viruses | Culture | Growth |
| Respiratory virusesa | Multiplex PCR | Positive | |
| Atypicalb | Multiplex PCR | Positive | |
| Blood | Aerobic bacteria | Culture | Growth |
| Virusesc | Complement fixation | Acute titer ≥120d or 4-fold increase | |
| Mycoplasma pneumoniae | Complement fixation | Acute titer ≥320d or 4-fold increase | |
| Pleural fluid | Bacteria | Culture | Growth |
NOTE. BAL, bronchoalveolar lavage; cfu, colony-forming units; NPA, nasopharyngeal aspirate; PCR, polymerase chain reaction.
Influenzavirus A and B; parainfluenza virus types 1, 2, 3; respiratory syncytial virus; human metapneumovirus subtypes A and B; coronavirus 229E and OC43.
M. pneumoniae and Chlamydophila pneumoniae.
Serological testing for influenzavirus A and B, adenovirus, picornavirus, and respiratory syncytial virus.
Reverse titer.